Respiratory Disease Testing Is Estimated To Witness High Growth Owing To Rising Prevalence Of Respiratory Diseases
Respiratory Disease The Respiratory Disease Testing Market is estimated to be valued at US$ 3,232 Mn in 2023 and is expected to exhibit a CAGR of 4.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The respiratory disease testing market covers testing solutions for various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), lung cancer, and various other respiratory infections. The testing includes imaging tests, respiratory measurement tests, blood gas tests, and other molecular diagnostic tests. These tests aid in early detection and diagnosis of respiratory diseases, enabling timely treatment interventions. Market Dynamics: The respiratory disease testing market is driven by the rising prevalence of respiratory diseases globally. As per the Centers for Disease Control and Prevention (CDC), in 2017, around 25 million adults and 8 million children in the U.S. ...